|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/24 | (2006.01) |
| A61K 39/395 | (2006.01) | ||
| C12N 15/13 | (2006.01) |
| (11) | Number of the document | 3444274 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18177227.8 |
| Date of filing the European patent application | 2009-06-25 | |
| (97) | Date of publication of the European application | 2019-02-20 |
| (45) | Date of publication and mention of the grant of the patent | 2020-12-23 |
| (46) | Date of publication of the claims translation | 2021-03-25 |
| (30) | Number | Date | Country code |
| 75640 P | 2008-06-25 | US | |
| 75692 P | 2008-06-25 | US | |
| 75697 P | 2008-06-25 | US | |
| 75956 P | 2008-06-26 | US | |
| 155041 P | 2009-02-24 | US |
| (72) |
Borras, Leonardo, CH
Gunde, Tea, CH
Urech, David, CH
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Stabilūs ir tirpūs antikūnai, slopinantys TNF |
| STABLE AND SOLUBLE ANTIBODIES INHIBITING TNF |
| Payment date | Validity (years) | Amount | |
| 2025-05-22 | 17 | 347.00 EUR |
| 2026-06-25 |